Powered by
Weekly: Helix BioPharma sinks 4.3% - trailing 85.7% of stocks March 03, 2017 17:00 EST
Mar 3, 2017 - News Bites Canadian Markets


Helix BioPharma Corp. (TSX:HBP), Canada's 15th largest Biotechnology company by market cap, has dropped 6.0c (or 4.3%) in the past week to close at CAD1.33. In the Canadian market of 1,933 stocks & 85 units traded today, the stock has a 6-month relative strength of 14 indicating it is trailing 86.0% of the market. Compared with the S&P/TSX 60 Index which rose 6.8 points (or 0.8%) in the week, this represented a relative price change of -5.1%. The volume was 0.1

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox